Latest Breaking News On - N espr us29664w1053 - Page 1 : comparemela.com

– Performance-Based Agreement Provides for Currax’s 72 Sales Representatives to Detail Esperion’s Products – – Reinforces Esperion’s Focus on Driving. | April 19, 2023

George hamptonSheldon koenigEsperion corporate communicationsExchange commissionMore than doubling sales teamCurrax pharmaceuticalsPerformance based agreement providesDetail esperionReinforces esperionDriving persistent growthChief executive officerPrescribing informationEsperion therapeuticsNc stock exchangePress releaseN espr us29664w1053